13-valent Pneumococcal Conjugate Vaccine + 7vPnC
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Vaccines, Pneumococcal
Conditions
Vaccines, Pneumococcal
Trial Timeline
May 1, 2007 → Jun 1, 2009
NCT ID
NCT00444457About 13-valent Pneumococcal Conjugate Vaccine + 7vPnC
13-valent Pneumococcal Conjugate Vaccine + 7vPnC is a phase 3 stage product being developed by Pfizer for Vaccines, Pneumococcal. The current trial status is completed. This product is registered under clinical trial identifier NCT00444457. Target conditions include Vaccines, Pneumococcal.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00444457 | Phase 3 | Completed |
Competing Products
20 competing products in Vaccines, Pneumococcal